Bispecific antibody targeting CD40 and HER2 potentiates therapeutic efficacy by reprogramming macrophages within the tumour microenvironment

Documenti analoghi

• Non‐apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages
  di: Chengpeng Sun, et al.
  Pubblicazione: (2024)
• The multifaceted roles of the ACSL family in cancer: Metabolic reprogramming, ferroptosis regulation and tumour immune microenvironment remodelling
  di: Haocai Li, et al.
  Pubblicazione: (2026)
• Mathematical model of tumor-macrophage interactions: Elucidating the tumor-driven macrophage phenotype reprogramming
  di: Zhang, Haifeng, et al.
  Pubblicazione: (2026)
• Engineered brain‐targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma
  di: Jun Yang, et al.
  Pubblicazione: (2024)
• UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion
  di: Nana Zhang, et al.
  Pubblicazione: (2025)